Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active compounds, particularly in pharmaceutical research. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of drug candidates targeting CNS disorders and oncology. Commonly employed in medicinal chemistry to introduce the triazolopyridine scaffold, which is known for its favorable pharmacokinetic properties and binding affinity to various enzymes and receptors.